Press releases
September 12, 2024
Inflammatix Secures $57 Million to Advance Novel Diagnostic for Patients with Suspected Infections or Sepsis
November 28, 2023
Inflammatix Receives Breakthrough Device Designation from FDA for TriVerity™ Acute Infection and Sepsis Test System
November 15, 2023
Inflammatix Completes Technical Development for TriVerity™ Acute Infection and Sepsis Test System
September 13, 2023
UMCG and Inflammatix Collaborate to Improve Early Recognition and Clinical Decision Support for Sepsis Care
July 10, 2023
Inflammatix Appoints Heiner Dreismann as New Board Member
June 15, 2022
Inflammatix Appoints Dr. Purvesh Khatri as Chief Scientific Officer
November 30, 2021
Inflammatix Appoints Dr. Kian Beyzavi as New Board Member
November 18, 2021
Inflammatix Announces Additional $12.1 Million Funding from BARDA for ViraBac EZ Acute Infection Test